Search -

Displaying 1 - 20 of 64

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

Caitlin E. Cox

April 01, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

Caitlin E. Cox

February 22, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Todd Neale

September 19, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

November 2025 Dispatch for the CV Team

September 2025 Dispatch for the CV Team

Healthcare Expenses Increase After GLP-1 Prescription

May 2025 Dispatch for the CV Team

GLP-1 Drugs May Have Role in Secondary Prevention of AF

AHA Statement Outlines Cardiac Contributions to Brain Health

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Antihypertensives Linked to Lower Long-term Dementia Risk

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Niacin, When Broken Down by the Body, Can Spur Inflammation

October 2023 News Roundup

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content